13-28311673-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_002019.4(FLT1):c.3552C>T(p.Tyr1184Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00274 in 1,613,416 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0020 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0028 ( 13 hom. )
Consequence
FLT1
NM_002019.4 synonymous
NM_002019.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.10
Publications
2 publications found
Genes affected
FLT1 (HGNC:3763): (fms related receptor tyrosine kinase 1) This gene encodes a member of the vascular endothelial growth factor receptor (VEGFR) family. VEGFR family members are receptor tyrosine kinases (RTKs) which contain an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and a tyrosine kinase (TK) domain within the cytoplasmic domain. This protein binds to VEGFR-A, VEGFR-B and placental growth factor and plays an important role in angiogenesis and vasculogenesis. Expression of this receptor is found in vascular endothelial cells, placental trophoblast cells and peripheral blood monocytes. Multiple transcript variants encoding different isoforms have been found for this gene. Isoforms include a full-length transmembrane receptor isoform and shortened, soluble isoforms. The soluble isoforms are associated with the onset of pre-eclampsia.[provided by RefSeq, May 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant 13-28311673-G-A is Benign according to our data. Variant chr13-28311673-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 775340.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.1 with no splicing effect.
BS2
High AC in GnomAd4 at 302 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00199 AC: 302AN: 152134Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
302
AN:
152134
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00176 AC: 443AN: 251378 AF XY: 0.00185 show subpopulations
GnomAD2 exomes
AF:
AC:
443
AN:
251378
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00281 AC: 4112AN: 1461164Hom.: 13 Cov.: 32 AF XY: 0.00279 AC XY: 2031AN XY: 726938 show subpopulations
GnomAD4 exome
AF:
AC:
4112
AN:
1461164
Hom.:
Cov.:
32
AF XY:
AC XY:
2031
AN XY:
726938
show subpopulations
African (AFR)
AF:
AC:
13
AN:
33464
American (AMR)
AF:
AC:
100
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
7
AN:
26118
East Asian (EAS)
AF:
AC:
1
AN:
39662
South Asian (SAS)
AF:
AC:
2
AN:
86248
European-Finnish (FIN)
AF:
AC:
9
AN:
53420
Middle Eastern (MID)
AF:
AC:
3
AN:
5758
European-Non Finnish (NFE)
AF:
AC:
3854
AN:
1111404
Other (OTH)
AF:
AC:
123
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
194
388
582
776
970
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00198 AC: 302AN: 152252Hom.: 1 Cov.: 32 AF XY: 0.00187 AC XY: 139AN XY: 74442 show subpopulations
GnomAD4 genome
AF:
AC:
302
AN:
152252
Hom.:
Cov.:
32
AF XY:
AC XY:
139
AN XY:
74442
show subpopulations
African (AFR)
AF:
AC:
18
AN:
41538
American (AMR)
AF:
AC:
57
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5180
South Asian (SAS)
AF:
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
216
AN:
68028
Other (OTH)
AF:
AC:
8
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
17
34
50
67
84
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
FLT1: BP4, BS2 -
Jul 25, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.